Ensysce Biosciences, Inc. (ENSC)

NASDAQ: ENSC · Real-Time Price · USD

0.5471

+0.0082 (1.52%)

At close: Mar 6, 2026, 4:00 PM EST

0.5200

-0.0271 (-4.95%)

After-hours: Mar 6, 2026, 7:59 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Biotechnology	5.21M	2.23M	2.52M	3.53M	3.93M
Biotechnology Growth	133.58%	-11.61%	-28.54%	-10.18%	122.86%
Total	5.21M	2.23M	2.52M	3.53M	3.93M
Total Growth	133.58%	-11.61%	-28.54%	-10.18%	122.86%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
United States	5.21M	2.23M	2.52M	3.53M	3.93M
United States Growth	133.58%	-11.61%	-28.54%	-10.18%	122.86%
Total	5.21M	2.23M	2.52M	3.53M	3.93M
Total Growth	133.58%	-11.61%	-28.54%	-10.18%	122.86%

Source: S&P Global Market Intelligence.